The Lancet Neurology is the leading journal in clinical neurology. We publish articles and reviews that advocate change in, or illuminate, clinical practice.
A Rapid Review published in our September issue discusses the post-viral effects of COVID-19 in the olfactory system and their implications thelancet.com/journals/laneu…
NEW #COVID19: Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
In their Correspondence, Hua Zhao and colleasgues higlight the need to consider potential neurological symptoms of SARS-CoV-2 infection
thelancet.com/journals/laneu…
Globally, #stroke is the second leading cause of death. The GBD 2019 Stroke collaborators call for urgent implementation of effective primary prevention strategies to curb the increasing burden of stroke: bit.ly/39bDZIx
The Boston criteria are used worldwide for the in-vivo diagnosis of CAA but have not been updated since 2010. In an Article, @a_charidimou and colleagues present updated criteria across the full spectrum of clinical CAA presentations. Read more at: thelancet.com/journals/laneu…
“Migraine remains one of the most stigmatised, underfunded, and underrecognised medical conditions”. Read our letter highlighting the @wfneurology campaign this #worldbrainday to reveal the painful truth about #migrainehubs.ly/H0jSLly0
Brain implants have helped a tetraplegic patient to control a whole-body exoskeleton with brain signals in a proof-of-concept demonstration: hubs.ly/H0l3Bz30
In their Review, Professor Nicolaas Bohnen and colleagues provide an update on cholinergic systems and changes in Parkinson's disease and isolated REM sleep behaviour disorder, a Parkinson's disease prodrome.
thelancet.com/journals/laneu…
NEW ISSUE: Read the latest content on chronic cluster headache, myasthenia gravis, cognitive impariment, Parkinson's disease, mitochondrial disease, and more
thelancet.com/journals/laneu…